Ryman’s turnaround is well under way: Forsyth Barr

Ryman’s turnaround is well under way: Forsyth Barr
Forsyth Barr's Aaron Ibbotson rates Ryman shares as "outperform". (Image: Forsyth Barr)
Jenny Ruth
Forsyth Barr analyst Aaron Ibbotson has taken a deep dive into Ryman Healthcare‘s debt position and its turnaround strategy and concluded it is “changing its stripes more than the market is giving it credit for”.The market has certainly exhibited extreme disillusion with the stock in recent weeks.Ryman shares fell as low as $4.82 after it completed its $902 million capital raising, compared with the rights issue price of $5 per new share and $6.40 before the mid-February announcement.The shares closed at $5.22 on Tuesday.A goo...

More Markets

Fonterra urges Canada to 'play by the rules'
Primary Sector

Fonterra urges Canada to 'play by the rules'

NZ, US and Australia believe Canada is undermining legitimate export interests.

Too few NZ ports earning 'appropriate returns'
Infrastructure

Too few NZ ports earning 'appropriate returns'

Port returns over the past decade 'disappointing and alarming'. 

Govt support needed to make sustainable aviation fuel
Markets

Govt support needed to make sustainable aviation fuel

Other countries may hesitate to export sustainable aviation fuel to NZ.